Company Comparison
Tango Therapeutics vs 10x Genomics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Tango Therapeutics | 10x Genomics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | — |
| Founded | — | — |
| Status | Active | Active |
| Last Funding Stage | — | — |
| Total Funding | — | — |
| Valuation | — | — |
What They Build
Tango Therapeutics
Tango Therapeutics develops precision oncology medicines using synthetic lethality approaches to target cancer vulnerabilities created by tumor suppressor gene loss.
10x Genomics
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
Key Investors
Sector Overlap
Both Tango Therapeutics and 10x Genomics operate in Biotech.
Browse all Biotech companies →